trending Market Intelligence /marketintelligence/en/news-insights/trending/HPMb8YJUuOPZwkyslLDhFg2 content esgSubNav
In This List

Valeant launches $1B debt offering


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Valeant launches $1B debt offering

Valeant Pharmaceuticals International Inc. launched a $1 billion debt offering to repurchase some of its existing notes.

Specifically, the company plans to repurchase its outstanding 5.375% senior notes, 7.00% senior notes and 6.375% senior notes, all due 2020.

The debt will be priced at a later date.

The company said it will also repay $175 million in outstanding amounts under its revolving credit facility in the week of Dec. 4 using available cash.

The notes will be guaranteed by each of Valeant's subsidiaries that are guarantors under the drugmaker's credit agreement and its existing senior notes.

Completion of the offering is subject to market and other conditions.